Sirtris to Go Public - Plans $60 Million IPO

[Guest guest]

This news came out last week, but I don't think anyone has posted

about it:

" Sirtris Pharmaceuticals, a much heralded startup company that aims

to beat age-related diseases by developing drugs that mimic the

effect of near starvation, has filed to go public.

The Cambridge, Massachusetts, company said Thursday [March 1] it

plans to raise $60 million in an initial public offering with J.P.

Securities leading a team of underwriters that includes CIBC

World Markets, Piper Jaffray, JMP Securities, and Rodman &

Renshaw....

In a government filing, Sirtris said it planned to apply the IPO

proceeds to develop SRT501, its proprietary formulation of

resveratrol, for Type 2 diabetes and new compounds that appear to

activate the same enzymes as those targeted by resveratrol. "

http://www.redherring.com/Article.aspx?a=21509 & hed=Longevity+Pharma+Firm+Sets+IP\

O

http://www.sirtrispharma.com/News/PressReleases/tabid/3693/Default.aspx

Fadden